Register entry
MAHI DRUGS PRIVATE LIMITED
- Registered sites
- 1
- Drug products
- 10
- Live patents
- 0
- Countries
- 1
- Base
- India
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufactureLabellingPackaging
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| MAHI DRUGS PRIVATE LIMITED | AnakapalliIndia | Analytical testing, Active ingredient (API) manufacture, Labelling, Packaging | 3019853340 |
Catalogue
Marketed products
10Showing 10 of 10.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Albendazole | POWDER | BULK INGREDIENT |
| - | Brinzolamide | POWDER | BULK INGREDIENT |
| - | Fosaprepitant Dimeglumine | POWDER | BULK INGREDIENT |
| - | Fosphenytoin Sodium | POWDER | BULK INGREDIENT |
| - | Hydroxyzine Hydrochloride | POWDER | BULK INGREDIENT |
| - | PI 301 | POWDER | BULK INGREDIENT |
| - | Squaric Acid Butyl Ester | POWDER | BULK INGREDIENT |
| - | Squaric Acid Dibutyl Ester | LIQUID | BULK INGREDIENT |
| - | Tiagabine Hydrochloride | POWDER | BULK INGREDIENT |
| - | Trazodone Hydrochloride | POWDER | BULK INGREDIENT |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.